Last reviewed · How we verify
NCT04248218
Concussion Active Rehabilitation
NA trial testing Active Rehabilitation Group/Case in Pediatric ALL in 55 participants. Completed in 30 June 2022.
30 January 2021
Quick facts
| Lead sponsor | Children's National Research Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 55 |
| Start date | 12 August 2019 |
| Primary completion | 30 January 2021 |
| Estimated completion | 30 June 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Active Rehabilitation Group/Case
Conditions studied
- Pediatric ALL — all drugs for Pediatric ALL →
- Concussion, Mild — all drugs for Concussion, Mild →
- Concussion, Brain — all drugs for Concussion, Brain →
- Concussion, Intermediate — all drugs for Concussion, Intermediate →
Sponsor
Children's National Research Institute
Who can join
Adults 8 to 18, any sex, with Pediatric ALL or Concussion, Mild. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, the investigator plans a randomized trial of active rehabilitation and standard care for acute concussion management. The investigator hypothesizes that patients with acute concussions managed with active rehabilitation will have decreased risk of prolonged concussion symptoms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04248218
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pediatric ALL
Currently open trials in the same condition.
- NCT07059624 — Femoral Arterial Cannulation in Pediatrics · NA · recruiting
- NCT06867289 — Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring · NA · recruiting
- NCT06325280 — Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease · recruiting
- NCT06274788 — Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome · recruiting
- NCT06096272 — Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy · NA · recruiting
Other Children's National Research Institute trials
Trials by the same sponsor.
- NCT07336264 — Characterization of Acute Pain · recruiting
- NCT06938542 — Palliative Care Needs of Children With Rare Diseases and Their Families · NA · enrolling by invitation
- NCT06618027 — Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes · NA · recruiting
- NCT06770010 — Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease · NA · recruiting
- NCT06623981 — The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04248218 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's National Research Institute
- Last refreshed: 30 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04248218.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing